(VIANEWS) - Targa Resources (TRGP), Exelixis (EXEL), Freeport (FCX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Targa Resources (TRGP)
67.7% sales growth and 11.04% return on equity
Targa Resources Corp., together with its subsidiary, Targa Resources Partners LP, owns, operates, acquires, and develops a portfolio of midstream energy assets in North America.
Targa Resources's sales growth this year is expected to be 76.9% and a negative 13.7% for next year.
Year-on-year quarterly revenue growth grew by 124.2%, now sitting on 11.74B for the twelve trailing months.
Volume
Today's last reported volume for Targa Resources is 1072640 which is 57.31% below its average volume of 2513140.
Targa Resources's sales growth for the next quarter is 67.7%. The company's growth estimates for the present quarter and the next is 28.6% and 181.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.04%.
Volatility
Targa Resources's last day, last week, and last month's current volatility was 2.92%, 2.05%, and 1.72%, respectively.
Targa Resources's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.61% (day), 2.94% (last week), and 3.40% (last month), respectively.
Targa Resources's Stock Yearly Top and Bottom Value
Targa Resources's stock is valued at $43.07 at 20:22 EST, way under its 52-week high of $49.20 and way above its 52-week low of $13.08.
Targa Resources's Moving Average
Targa Resources's worth is higher than its 50-day moving average of $42.82 and way above its 200-day moving average of $38.00.2. Exelixis (EXEL)
60.6% sales growth and 4.85% return on equity
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States.
Exelixis's sales growth this year is anticipated to be 39.1% and 16.7% for next year.
Year-on-year quarterly revenue growth grew by 48.4%, now sitting on 1.16B for the twelve trailing months.
Volume
Today's last reported volume for Exelixis is 1382230 which is 42.59% below its average volume of 2407810.
Exelixis's sales growth for the next quarter is 60.6%. The company's growth estimates for the ongoing quarter and the next is a negative 71.4% and 240%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.85%.
Volatility
Exelixis's last day, last week, and last month's current volatility was 0.75%, 2.60%, and 1.90%, respectively.
Exelixis's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.77% (day), 3.18% (last week), and 3.39% (last month), respectively.
Exelixis's Stock Yearly Top and Bottom Value
Exelixis's stock is valued at $18.93 at 20:22 EST, way under its 52-week high of $27.35 and way above its 52-week low of $16.19.
Exelixis's Moving Average
Exelixis's value is higher than its 50-day moving average of $17.49 and way under its 200-day moving average of $21.54.Previous days news about Exelixis(EXEL)
- Kinaxis partners with exelixis to advance supply chain planning for its cancer drug portfolio. According to Benzinga on Thursday, 26 August, "We are looking forward to working with Exelixis to build a more agile and transparent supply chain that will ultimately better serve those relying on the company's medicines.", "With Kinaxis, Exelixis gains the ability to plan for every scenario and immediately see how changes affect the entire supply chain. "
3. Freeport (FCX)
52.1% sales growth and 18.77% return on equity
Freeport's sales growth this year is expected to be 63.4% and 9.6% for next year.
Year-on-year quarterly revenue growth grew by 88.2%, now sitting on 18.94B for the twelve trailing months.
Volume
Today's last reported volume for Freeport is 10897300 which is 47.06% below its average volume of 20586100.
Freeport's sales growth is a negative 0% for the current quarter and 52.1% for the next. The company's growth estimates for the current quarter and the next is 172.4% and 115.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.77%.
Volatility
Freeport's last day, last week, and last month's current volatility was 0.28%, 2.63%, and 2.43%, respectively.
Freeport's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.43% (day), 2.59% (last week), and 3.29% (last month), respectively.
Freeport's Stock Yearly Top and Bottom Value
Freeport's stock is valued at $34.54 at 20:22 EST, way below its 52-week high of $46.10 and way higher than its 52-week low of $14.37.
Freeport's Moving Average
Freeport's worth is under its 50-day moving average of $35.73 and below its 200-day moving average of $36.85.Previous days news about Freeport(FCX)
- According to Benzinga on Monday, 23 August, "U.S.-based giants like Newmont (NYSE: NEM), Freeport McMoRan (NYSE: FCX) and Albemarle (NYSE: ALB) are likely looking to capitalize on American policy. "
4. Tenaris S.A. (TS)
50.5% sales growth and 4.03% return on equity
Tenaris S.A., through its subsidiaries, produces and sells seamless and welded steel tubular products; and provides related services for the oil and gas industry, and other industrial applications.
Tenaris S.A.'s sales growth this year is anticipated to be 12% and 18.7% for next year.
Year-on-year quarterly revenue growth grew by 23.2%, now sitting on 4.85B for the twelve trailing months.
Volume
Today's last reported volume for Tenaris S.A. is 1705660 which is 7.19% below its average volume of 1837930.
Tenaris S.A.'s sales growth for the next quarter is 50.5%. The company's growth estimates for the ongoing quarter and the next is 375% and 566.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.03%.
Volatility
Tenaris S.A.'s last day, last week, and last month's current volatility was 2.47%, 1.68%, and 1.57%, respectively.
Tenaris S.A.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.50% (day), 2.20% (last week), and 2.23% (last month), respectively.
Tenaris S.A.'s Stock Yearly Top and Bottom Value
Tenaris S.A.'s stock is valued at $19.49 at 20:22 EST, way under its 52-week high of $24.15 and way higher than its 52-week low of $8.86.
Tenaris S.A.'s Moving Average
Tenaris S.A.'s worth is under its 50-day moving average of $20.36 and below its 200-day moving average of $21.52.5. Kadant (KAI)
38.2% sales growth and 14.65% return on equity
Kadant Inc. supplies equipment and critical components worldwide.
Kadant's sales growth this year is expected to be 24.5% and 10.2% for next year.
Year-on-year quarterly revenue growth grew by 28.1%, now sitting on 691.32M for the twelve trailing months.
Volume
Today's last reported volume for Kadant is 15513 which is 46.96% below its average volume of 29249.
Kadant's sales growth is a negative 0% for the ongoing quarter and 38.2% for the next. The company's growth estimates for the current quarter and the next is 42.5% and 34.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.65%.
Volatility
Kadant's last day, last week, and last month's current volatility was 0.29%, 0.69%, and 1.83%, respectively.
Kadant's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.31% (day), 2.53% (last week), and 3.09% (last month), respectively.
Kadant's Stock Yearly Top and Bottom Value
Kadant's stock is valued at $201.41 at 20:22 EST, under its 52-week high of $208.95 and way above its 52-week low of $104.15.
Kadant's Moving Average
Kadant's value is above its 50-day moving average of $185.51 and way higher than its 200-day moving average of $176.06.Previous days news about Kadant(KAI)
- Kadant acquires leading U.S. baler manufacturer. According to Benzinga on Monday, 23 August, "WESTFORD, Mass., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE:KAI) today announced it has completed its acquisition of Balemaster for $54 million in cash, subject to certain customary adjustments.", "We are excited to welcome the employees of Balemaster to the Kadant family."
6. Elbit Systems Ltd. (ESLT)
11.1% sales growth and 11.14% return on equity
Elbit Systems Ltd.
Elbit Systems Ltd.'s sales growth this year is anticipated to be 7.7% and 5.1% for next year.
Year-on-year quarterly revenue growth grew by 20.7%, now sitting on 4.93B for the twelve trailing months.
Volume
Today's last reported volume for Elbit Systems Ltd. is 171175 which is 275.64% above its average volume of 45568.
Elbit Systems Ltd.'s sales growth for the next quarter is 11.1%. The company's growth estimates for the current quarter and the next is 0.6% and 2.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.14%.
Volatility
Elbit Systems Ltd.'s last day, last week, and last month's current volatility was 0.16%, 0.71%, and 1.59%, respectively.
Elbit Systems Ltd.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.14% (day), 1.94% (last week), and 1.85% (last month), respectively.
Elbit Systems Ltd.'s Stock Yearly Top and Bottom Value
Elbit Systems Ltd.'s stock is valued at $145.83 at 20:22 EST, under its 52-week high of $147.22 and way higher than its 52-week low of $110.69.